fda warning letter compounding semaglutide news warnings against compounded GLP-1s raise the stakes for telehealths selling branded drugs Last month, the FDA issued

Primary melanoma of the lung

W., & Leggio, L

Skin brightening effects typically become noticeable after 3-4 weeks of consistent treatment, with optimal results appearing after 2-3 months

BPC 157 Therapy to Detriment Sphincters Failure-Esophagitis-Pancreatitis in Rat and Acute Pancreatitis Patients Low Sphincters Pressure

The ad is a clear violation of the Federal Food, Drug, and Cosmetic Act (FDCA), which requires that advertising for prescription drugsincluding compounded drugsnot be false or misleading. In addition, PhRMA admonished Hims & Hers for appearing to violate guidelines set by the Alliance for Pharmacy Compounding, which say non-FDA-approved drugs cant be promoted as safe and effective for treating a particular condition

Preliminary results with retatrutide from TRIUMPH-4 in participants with obesity or overweight and osteoarthritis